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Abstract  
Cancer remains a leading cause of death in the state of Arkansas and across the 
United States. Recent research found that peanuts consumption has been correlated with a 
decreased risk of cancer. Although limited research has been conducted, phenolic 
antioxidant compounds found in peanuts, arachidin-1 and arachidin-3, are correlated to a 
decrease in human leukemia and lung cancer cell growth. The objective of this study was 
to evaluate the anti-colon cancer effects of these compounds. Experiments were 
conducted to examine the effects of purified arachidin-1 and arachidin-3 on Caco-2 cell 
proliferation. Treatment of cells with arachidin-1 (0, 1, 5, 10µM) and arachidin-3 (0, 5, 
10, 20µM) were measured at time points 0, 24, and 48 hours. There was cell reduction for 
10 and 20µM treatments of arachidin-3 at time point 24 hours, but no other significant 
reduction was found. The findings suggest that arachidin-1 and arachidin-3 did not inhibit 
the growth of human colon cancer cells. Further research needs to be conducted to 
examine the effects of peanuts stilbenoids, arachidin-1 and archidin-3, as potential 
anticarcinogenic agents. 
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Chapter I. Introduction  
Globally, each year about 14 million individuals learn they have cancer while 8 
million people die from the disease (CDC, 2014). Cancer is the second leading cause of 
mortality in the United States. Colorectal cancer is the third leading cause of cancer death 
and approximately 5%, or every 1 in 20 Americans, will be diagnosed with cancer of the 
rectum or colon in their lifetime (ACS, 2014). In the state of Arkansas, there is a rate of 
41.7 per 100, 000 men and women per year compared to the national rate (42.4 per 100, 
000). But Arkansas has a higher death rate (17.9 per 100,000) than the national rate (15.5 
per 100,000) (Holt et al., 2011). 
Epidemiologic studies have identified an inverse association between diet rich in 
fruits and vegetables and cancer (Chen et al., 2015). A variety of fruits and vegetables 
contain bioactive components, antioxidants, which have been linked to chemoprevention 
of colon cancer (Amin et al., 2009). 
Peanuts (Arachis hypogaea L.) contain high concentrations of polyphenolic 
antioxidants. Of the bioactive compounds in peanuts much attention has been on the 
phenolic antioxidant, resveratrol (trans-3,5,49- trihydroxystilbene), a family of 
stilbenoids. Previous research on resveratrol and polydatin (resveratrol-3-O-b-mono- D-
glucoside) has indicated that stilbenoid compound polydatin alone or with resveratrol 
caused the Caco-2 cell (a human epithelial colorectal adenocarcinoma cell) death by 
apoptosis (De Maria et al., 2013). Arachidin-1 [trans-4-(3-methyl-1-butenyl)-3,5,3’,4’-
tetrahydroxysilbene)], and arachidin-3 [(Arachidin-3, trans-4-(3-methyl-1-butenyl)-
3,5,4’-trihydroxystilbene)] also belong to a family of stilbenoids derived from the root of 
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a peanut plant. However, there is limited information available on health-promoting 
activities of arachidin-1 and arachidin-3.  
The goal of this study is to determine the effects of arachidin-1 and arachidin-3 on 
human colon cancer cells. The objectives of this study were to: 1) determine if arachidin-
1 and arachidin-3 can inhibit colon cancer cell growth and 2) determine what 
concentrations of arachidin-1 and arachidin-3 are effective at inhibiting cell proliferation. 
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Chapter II: Literature Review 
 
Colon Cancer  
Colorectal cancer is the third most common cancer diagnosed in both men and 
women in the United States (NIH, 2016). CRC is cancer that starts in the colon or rectum. 
The colon and the rectum are parts of the large intestine, which is the lower part of the 
body’s digestive system (CDC, 2014). The function of the colon is to absorb water and 
salt from the food matter and to serve as a storage place for waste matter. It is composed 
of four different sections: ascending colon, transverse colon, descending colon, and 
sigmoid colon (NIH, 2016).  
Colorectal cancer incident and mortality rates are dependent on sex, race, age, and 
ethnicity (Figure 1). From 2002 to 2011 in the United States the incident rate of 
colorectal decreased significantly by 3.6% per year among men and by 3.2% per year 
among women. While in the same years, the death rate decreased significantly by 3.1% 
per year among men and by 2.9% per year among women (CDC, 2014). Although there 
is a decrease, in the United States for 2015 the number of CRC cases was projected to be 
132,700 new cases of colon and rectum cancer and 49,700 deaths (NIH, 2016).  
Risk factors of colorectal cancer include age, race, sex, heredity, preexisting 
conditions and lifestyle factors such as: physical activity, diet, overweight, alcohol 
consumption, and tobacco use (CDC, 2014). There is much evidence linking the 
‘Western’ diet (high fat and low fiber content) to increased risk of CRC. Diets are under 
review as there is a correlation to a higher risk of CRC if a diet consists of a large amount 
of red meat or processed meats, but a lower risk of CRC if the diet is high in fruits and 
vegetables (NIH, 2016). 
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 Figure 1: Colorectal Cancer Incident and Mortality Rates* by Race/Ethnicity and Sex, 
2006-2010 (ACS, 2014). *Rate are per 100,000 
 
Since diet is a risk factor linked to colorectal cancer, researchers have investigated 
whether consuming dietary antioxidants can help lower the risk of developing cancer in 
humans. An antioxidant is a chemical substance that slows down or prevents the damage 
that oxygen does to organisms or food. Currently research is being conducted looking at 
specific antioxidants and the effects on cancer, heart disease, stroke, and other diseases 
associated with aging.  
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General Information about Peanuts 
Nutrients in Peanuts 
Peanuts (Arachis hypogaea L.), a type of legume, are known for their source of protein 
and energy. For every 100 grams of peanuts there is approximately 585 kilocalories, 
21.51 grams of carbohydrates, 8.0g of fiber, and 49.66g of fats, and 23.68g of proteins. 
With the exception of meat, legumes, such as peas, beans, and peanuts contain a large 
amount of protein, more than any other nuts (Settaluri et al., 2012). Peanuts are composed 
of nutrients, minerals, and vitamins that are essential for optimum health.  
Table 1. Composition by weight* of biomolecules in peanuts (Adapted from Settaluri et 
al., 2012) 
Amino acids  Vitamins  
Type Weight (g)* Type Weight (g)* 
Tryptophan 
Threonine 
Isoleucine 
Leucine 
Lysine 
Methionine 
Cysteine 
Phenylalanine 
Tyrosine 
Valine 
Arginine 
Histidine 
Alanine 
Aspartic acid 
Glutamic acid 
Glycine 
Proline 
Serine 
 
0.230 
0.811 
0.833 
1.535 
0.850 
0.291 
0.304 
1.227 
0.963 
0.993 
2.832 
0.599 
0.941 
2.888 
4.949 
1.427 
1.045 
1.167 
Thiamin 
Riboflavin 
Niacin 
Pantothenic acid 
B6 
Folate 
E** 
Choline 
 
Minerals 
Calcium 
Iron 
Magnesium 
Phosphorous 
Potassium 
Sodium 
Zinc 
Manganese  
0.438x10-3 
0.098x10-3 
13.525x10-3 
1.395x10-3 
0.256x10-3 
1450x10-6 
6.93x10-3 
55.3x10-3 
 
 
54x10-3 
2.26x10-3 
176x10-3 
358x10-3 
658x10-3 
6x10-3 
3.31x10-3 
2.083x10-3 
 
Lipids  Others  
Total saturated fatty acid 
Total monounsaturated 
Total polyunsaturated 
 6.893 
24.640 
15.694 
 
Carbohydrates (total) 
Dietary fiber 
Sugar (total) 
21.51 
8.0 
4.18 
 
*Quantities expressed are per 100g of dry-roasted peanuts, all types, and without salt. **This is a fat 
soluble vitamin and the rest are water soluble vitamins 
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 Peanuts dietary protein contains amino acids essential for growth and development. 
Additionally, they are great sources of folate, manganese, niacin – which contributes to 
brain health and blood flow to brain, and vitamin E – a powerful lipid solvent 
antioxidant.  
Health Benefits of Peanuts  
Peanuts are one of the widely cultivated oil-seed and established prime 
commercial crops in the world. The health benefits of peanuts are becoming a rising topic 
for researchers as well as nutritionists. In recent years, research has shown that peanuts 
could be linked to reduced weight gain and especially correlated with different functions 
in the digestive system (Bes-Rastrollo et al., 2007). Women age 30-55 years had no 
history of gallstone disease was studied in a 20-year cohort study. Women who consumed 
at least one ounce of peanuts and/or other nuts each week had a significantly lower risk of 
cholecystectomy than women who did not eat nuts (Tsai et al., 2004). In a different 
cohort study of 8,866 individuals, it was found that those who ate nuts—walnuts, 
almonds, hazelnuts, and peanuts— at least twice a week were much less likely to gain 
weight of 5 kilograms or more than those who almost never ate nuts (Bes-Rastrollo et al., 
2007). In another 10-year cohort study beginning in 1990, the consumption of peanuts 
and a reduced risk of colorectal cancer were correlated. 12,026 men and 11,917 women 
aged 30 to 65 years, who were residents in 7 townships in Taiwan, were annually 
followed by evaluating weekly food measures. Their findings suggest that women who 
consumed peanuts had a much lower risk of colorectal cancer. It is indicated that some 
specific components in peanuts inhibit the carcinogenic mechanisms of colorectal cancer, 
but other studies must be conducted in order to rule out other factors that might have been 
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present (Yeh et al., 2006). A following step could be to determine what specific 
component(s) do peanuts possess that could be linked to one or more of these 
advancements in human health mentioned above. Recent discovery of bioactive 
components in naturally occurring food has allowed research to continue to conduct more 
specific studies by researching one or more of the components in food directly. The 
ability to test only certain bioactive components are crucial for both the research of food 
industries as well as research regarding human biological processes and diseases. As 
mentioned above, there are many studies correlating health benefits and peanuts. With 
increased research with certain bioactive components experimenters can see more 
specific correlations and possibly extend information to other areas especially for human 
health.  
Bioactive Components in Peanuts  
Bioactive compounds are extra nutritional constituents that typically occur in 
small quantities in foods (Kris-Etherton et al., 2002). Currently bioactive components 
(which are varied by the number of hydroxyl groups and isopentenyl moiety) in peanuts 
are on the forefront of research as they are able to prevent or slow the growth of cancers, 
contain antioxidants, and even extend lifespans (Chang et al., 2006). Polyphenols, 
antioxidants, are abundant in fruits and vegetables, and evidence for their role in the 
prevention of degenerative diseases such as cancer and cardiovascular diseases is 
emerging (Manach et al., 2004).  The health effects of polyphenols depend on the amount 
consumed and on their bioavailability (Manach et al., 2004). Not only do polyphenols 
have antioxidant properties, but also they have other have a variety of biological activities 
that are yet to be understood (Manach et al., 2004). Polyphenols are composed of a 
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subcategory named natural stilbenoids, which are a family of polyphenols known for 
their diverse biological activities.  Recently, it was found that the stilbenoid antioxidants 
and resveratrol (trans-3,5,4’- trihydroxystilbene), found in peanuts seeds and red grapes 
has been determined to improve blood flow in the brain by as much as 30%, thus greatly 
reducing the risk of stroke (Peanuts, 2015). Previous research on polydatin, (resveratrol-
3-O-b-mono- D-glucoside, Product Origin: Root of Polygonum cuspidatum), a natural 
precursor of resveratrol, reported that polydatin alone or with resveratrol caused the 
Caco-2 cell (a human epithelial colorectal adenocarcinoma cell) death by induction of 
apoptosis (De Maria et al., 2013). Although resveratrol (trans-3,5,4’- trihydroxystilbene) 
has received considerable attention as a putative anticancer agent, a study found that 
other peanuts prenylated stilbenoids, arachidin-1 and archidin-3, may be preferable 
alternatives due to increased bioavailability via slowed metabolism (Brents et al., 2012).  
Due to the similar chemical structures of resveratrol, arachidin-1 (trans-4-(3-methyl-1-
butenyl)-3,5,3’,4’-tetrahydroxysilbene), and arachidin-3 (Arachidin-3, trans-4-(3-methyl-
1-butenyl)-3,5,4’-trihydroxystilbene) are now specifically being studied. Arachidin-1 and 
arachidin-3 belong to a family of stilbenoids derived from the root of a peanuts plant. 
Current research is limited due to the recent discovery of these bioactive components.  
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Figure 2. Chemical Structures of 1. Resveratrol (trans-3,5,4’- trihydroxystilbene) 2. 
Arachidin-1 trans-4-(3-methyl-1-butenyl)-3,5,3’,4’-tetrahydroxysilbene; 3. Arachidin-3, 
trans-4-(3-methyl-1-butenyl)-3,5,4’-trihydroxystilbene (Adapted from Soboley 2013). 
 
 Biological Activities of Arachidin-1 and Arachidin-3  
Prenylated stilbene compounds in peanuts such as arachidin-1 (Ara-1) and 
arachidin-3 (Ara-3) are beginning to be studied in vitro experiments in order to 
understand these compounds and the functions that they possess. It was found that both 
of these compounds possess a defense mechanism against physical injuries and fungal 
contamination when challenged by a fungal strain (Liu et al., 2013). Prenylated Ara-1 and 
Ara-3 improved glucuronidation profiles (Brents et al., 2012). In addition, both Ara-1 and 
Ara-3 showed a significant decrease in Rotavirus Gastroenteritis viral replication when 
applied (Ball et al., 2015). This study found that the effects of the compounds, Ara-1 and 
Ara-3, were dose- and time- dependent to decrease viral progeny when they were applied 
to both the Rotavirus within human intestinal cells. It is indicated that the prenylated side 
1	
2
3 
1
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chain of Ara-1 and Ara-3 promotes invasion through cell membranes more than 
resveratrol due to the increased lipophilicity to the attached molecules (Ball et al., 2015). 
Compounds, Ara-1 and Ara-3, are being used in a variety of experiments with viruses, 
fungal strains, and possible therapeutic values for chronic disease, but they are commonly 
used in exposure to cancer cells. (Liu et al., 2013). In recent studies Ara-1 had the highest 
efficacy in inducing programed cell death in Human Leukemia cells HL-60 with an 
approximately 4-fold lower EC50 than resveratrol. Specifically Ara-1 caused 
mitochondrial membrane damage, released apoptosis-inducing factor, and activation of 
caspases (Huang et al., 2010). Ko and colleagues in 2013, reported that arachidin-1 
decreased thymidine phosphorylase (TP) and Excision repair cross-complementation 1 
(ERCC1), both with high amounts in cancer cells are associated with poor prognosis. In 
addition, arachidin-1 combined with Metformin, a type two diabetic drug, significantly 
decreased TP and ERCC1 in human lung cancer (NSCLC) cell lines (Ko et al., 2013).  
 
Table 2. Summary of anticarcinogenic activities of arachidin-1 arachidin-3, and 
resveratrol (in vitro studies). 
 
 
 
 
Phenolic 
Compound  
Cell Line Concentration  Effect  Time 
Resveratrol, 
Polydatin 
(De Maria et 
al., 2013) 
Caco-2 cells, 
differentiated 
and 
undifferentiated 
Different 
concentrations: 
0 to 500µM of 
each or 
combination 
(50:50, 75:25 
molar ratio) 
IC50: 190µM 
Pol and 373µM 
Res in 
differentiated 
 
polydatin alone 
has a stronger 
cytotoxicity, 
antiproliferative 
effect poly:res 
3:1 
24 hours 
14	
*IC50: the dose that causes half-maximal inhibition by antagonist 
** EC50: the concentration resulting in a 50% decrease in cell viability (Cheng-Po et al., 
2010) 
 
Phenolic 
Compound  
Cell Line Concentration  Effect  Time 
Arachidin-1, 
Arachidin-3, 
Resveratrol 
(Cheng-Po et 
al., 2010) 
Human 
leukemia HL-
60 
 
0 to 20 µM 
treating with 
Ara-1 and Ara-
3 
EC50 values of 
4.2 µM Ara-1, 
18.9 µM Ara-3, 
and 17.6 µM 
resveratrol 
0-72 hours 
Metformin 
(diabetic 
drug), 
Arachidin-1  
(Ko et al., 
2013) 
 
A549 and 
H1975 Lung 
cancer cells 
 
0.5, 1, 5 and 
10 µM Ara-1 
and 25 µM 
metformin 
 
5, 10, 25 and 
50 µM 
metformin and 
0.5µM Ara-1 
 
Ara-1 (0.5 
µM) were 
added for 24 hr 
Greater loss of 
cell viability 
with both 
metformin and 
Ara-1 
Treated with 
metformin, 
Ara-1 or both 
for 24hr 
Arachidin-1 
Arachidin-3  
Resveratrol 
Piceatannol 
(Ball et al., 
2015) 
Rotavirus 
Gastroenteritis 
HT29 (Human 
intestinal line 
infected with 
Rotavirus) 
10, 20 µM 
Ara-1, 
10, 20 µM 
Ara-3 
Ara-1 10 µM 
tenfold 
decrease, 20 
µM twenty-
fivefold 
decrease 
Ara-3 10 µM 
ninefold 
decrease, 20 
µM ninety-
eightfold 
decrease  
in virus 
infectivity titer 
12 and 24 
hours 
postinfection 
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Chapter III: Materials and Methods 
Materials  
 Arachidin-1 (Ara-1) and arachidin-3 (Ara-3) compounds were generously donated 
by Dr. Medina-Bolivar (Arkansas State University, Jonesboro, AR). All media 
components and reagents were obtained from Gibco® through ThermoFisher (Waltham, 
MA).  
Methods  
HPLC Analysis  
A System Gold high performance liquid chromatograph (Beckman-Coulter, 
Fullerton, CA, USA) with autosampler (model 508), dual pump (model 126), photodiode 
array detector (model 168) with Beckman-Coulter System 32 Karat software (version 8, 
2006) was used to analyze the arachidin-1 and arachidin-3. The compounds were 
separated using an adapted method of Abbott et al (2010). Separation was performed 
using a Phenomenex (Torrance, CA) Aqua 5µm C18 (250 × 4.6 mm) column using a 
binary gradient of 2% formic acid for mobile phase A and 99:1 (v/v) acetonitrile/mobile 
phase A.  The initial conditions of the gradient were 10% B, then increased linearly from 
10-18% for 8 min, and was held at 18% B for 2 minutes. Next, B increased linearly to 18-
25% over 5 min, 25-35% B for 3 min, and held isocratically for 20 min, then %B 
increased 35-60% linearly for 60 min before returning to the initial 10%B.  Peaks were 
monitored at 340 nm refer to Figure 3. 
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Cell Culture 
A human epithelial colorectal adenocarcinoma cell line (Caco-2 cells) was 
purchased from the American Type Culture Collection (ATCC, Rockville, MD). The 
cells were at passage number 18 (passage number refers to the number of times the cell 
line has been re-plated) and cultured in Working Media (W-MEM). W-MEM is 
composed of 10% fetal bovine serum (FBS), 2% antibiotic-antimicotic solution, 1% Non-
essential amino acids, and Dulbecco’s modified eagle’s medium (DMEM). Cell cultures 
were maintained under strict sterile conditions incubated at 37°C, 70% humidity, and 5% 
CO2 in the incubator (VWR® symphony ™, VWR® International LLC, Radnor, PA).  
Cell Proliferation Assay  
 Cells, passage number 22-25, were used for the proliferation assays. The effects 
of Ara-1 and Ara-3 on the cellular proliferation and viability of Caco-2 cells were 
measured using CellTiter 96® Aqueous One Solution Proliferation Assay (Promega Cor. 
Madison, WI). CellTiter 96® contains tetrazolium compound [3-(4,5-dimethyl-2-yl)-5-
(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt; MTS] and an 
electron coupling reagent (phenazine ethosulfate; PES). This assay is a colorimetric 
method to determine the number of viable cells in proliferation or cytotoxicity assays. 
The tetrazolium compound becomes reduced by living cells into a colored formazan 
product, which is soluble in culture media. The amount of reduced tetrazolium is 
measured by a plate reader resulting in a directly proportional number of living cells in 
the culture.  
 To conduct this MTS assay, Caco-2 cells (2 x 103) in 200µl of W-MEM were 
seeded in the wells of a 96 well plate. Cells were incubated at 37°C, 70% humidity, and 
17	
5% CO2 for 24 hours to allow attachment of the cells to the bottom of the wells. After 24 
hours, the media was aspirated and replaced with different concentrations of a compound 
(either Ara-1 or Ara-3) and control. Treatment media containing Ara-1 at concentrations 
of 1, 5, and 10µM and Ara-3 at concentrations of 5, 10, and 10µM. A negative control of 
0.1% DMSO in 10% FBS W-MEM was used to measure the viability of Caco-2 cells in 
the absence of compounds. Treatments and negative controls were done in triplicate. 
Viability measurements were made at time 0hr, 24hr, and 48hr after the addition of the 
compounds or control. Time 0hr refers to the time of applying treatment.  
 CellTiter reagent was directly added to the cells, 40µl per well. The reagent was 
added to all wells (including wells with cells and to wells only with compounds where no 
cells are present, a sample control). Microplates were incubated for 2 hours after the 
addition of the reagent, before measuring the absorbance at 490nm with the plate reader 
(Synergy HT Multi-Mode Microplate Reader, BioTek Instruments, Inc. Winooski, VT). 
Once the absorbance readings were made, data was corrected for the background 
absorbance of the wells with negative control media or with wells with compounds 
without cells. Corrected absorbance numbers were converted into cell numbers using an 
equation from the Caco-2 cell standard curve.  
A standard curve was composed of serial dilution of cells prepared in triplicate in 
a 96 well plate ranging from 32000 cells to 0 cells with W-MEM. The standard curve was 
created by seeding cells in the actual experiment adding CellTiter reagent directly to the 
wells, and then measuring the absorbance of these cells. The results of standard curve of 
the 0hr plate were plotted to compare the change in absorbance as the total cell number 
increased. Each experiment conducted used the equation given from data plotted to 
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calculate the cell numbers to plot cell growth curves. Cell viability was checked at time 
points of 24hr and 48hr with cell counts ranging from 32000 to 2000.  
Statistical Analysis  
Values were expressed means ± standard error of the mean (SEM). Data was 
analyzed using Statistical Analysis System (Version 9.4; SAS Institute Inc., Cary, NC). A 
one-way analysis of variance was used to show significant differences from the control 
cells at each time point. An alpha level of 0.05 was used to determine statistically 
significant differences. Fisher’s least significant difference (LSD) test was used to 
analyze the data.  
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Chapter IV: Results  
HPLC Results 
The High Performance Liquid Chromatogram (HPLC) analysis confirmed the 
identity of compounds used for this experiment: arachidin-1 and arachidin-3. The results 
are summarized in Figure 3.  
Figure 3. High Performance Liquid Chromatogram of arachidin-1 and arachindin-3 at 
340nm.	
 
Cell Standard Curve 
 In order to differentiate outside factors from treatment cells, a standard curve was 
used as a control on every plate. This was used as a reference for cell growth and 
conditions on each cell plate throughout the experiment. Figure 4 shows the standard 
curve of Caco-2 cells.  
  
 
Arachidin	1	
Arachidin	3	
20	
Figure 4. Caco-2 cell standard curve 
  
Cell Proliferation 
Treatment of Caco-2 Cells with arachidin-1 did not decrease cell proliferation 
compared to control (Figure 5). There is a difference between 10mM cell growth 
compared to the control (0µM), 1µM, and 5µM. At both time points of 24 and 48 hours 
for arachidin-1, 10µM treatment seemed to promote cell growth compared to the control, 
treatment of 1µM and 5µM. The effectiveness of reduced cell proliferation for arachin-1 
was not correlated with concentration at time points 24 and 48 hours.  
Figure 6 shows the effects of arachidin-3 on the survival of Caco-2 cells. 
Compared with the control and 5µM of arachidin-3, treatments of 10µM and 20µM of 
arachidin-3 resulted in a significant reduction of cell number at time point 24 hours 
(P<0.05). At time point 48 hours there was not a significant difference between the any of 
the treatments of arachidin-3.  
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Figure 5. Effect of arachidin-1 on the survival of Caco-2 cells. Values are 
mean + standard error of the mean (SEM). Values with different letters at the 
same incubation time are significantly different (P<0.05). 
 
 
 
 
Figure 6. Effect of arachidin-3 on the survival of Caco-2 cells. Values are 
mean + standard error of the mean (SEM). Values with different letters at the 
same incubation time are significantly different (P<0.05). 
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Chapter V: Discussions 
 
Peanuts (Arachis hypogaea L.) contain many nutrients, antioxidants, vitamins, 
and minerals essential to optimal health (Settaluri et al., 2012). Peanuts have been linked 
to reduced weight gain to reduced risk of heart disease (Bes-Rastrollo et al., 2007; 
Settaluri et al., 2012).  
The present study investigated the effects of stilbenoids (arachidin-1 and 
arachidin-3) found in peanuts root on colon cancer cells (Caco-2 cells) proliferation. No 
significant reduction of cell growth with arachidin-1. There was a significant increase of 
proliferation at time point 24 and 48 hours for 10µM treatment of arachidin-1. However, 
there was a significant difference in inhibition of cell growth for treatments 10µM and 
20µM of arachidin-3, but none of the treatments showed a significant difference at time 
point 48 hours. Further research should include higher concentrations of arachidin-1 and 
arachidin-3 on Caco-2 cell growth. 
There have been a few in-vitro studies regarding the anti-proliferative behavior of 
arachidin-1 and arachidin-3, but there is a variation in results and concentrations of these 
compounds between studies. These studies have reviewed different cells lines and 
combined alternative drugs or naturally occurring compounds combined with arachidin-1 
and arachidin-3 (De Maria et al., 2013, Cheng-Po et al., 2010, Ko et al., 2013, Ball et al., 
2015). There was only one study found to look at Caco-2 cells combining antioxidant 
agents, resveratrol and Polydatin (De Maria et al., 2013). Due to the limited research of 
compounds arachidin-1 and arachidin-3 effects on Caco-2 cells, there could be a different 
concentration needed to inhibit proliferation. A study on human leukemia cell line 
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suggested that arachidin-1 should be more potent than arachidin-3, but this study was not 
able to concur with these results (Cheng-Po et al., 2010). Based on previous studies 
concentrations of treatments varies depending on cell line experimented (De Maria et al., 
2013, Cheng-Po et al., 2010). Due to the limited research with Caco-2 cell line with 
peanuts stilbenoids more research need to be conducted to fully understand the effects of 
these compounds.  
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Chapter IV: Conclusions 
 
The results of the present study suggest that arachidin-1 and arachidin-3 did not 
inhibit the growth of human colon cancer cells. In order to understand the biological 
activities of these compounds more studies need to be conducted.  
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